Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
32.27
+0.42 (1.32%)
Feb 4, 2026, 2:45 PM CST
SHA:603882 Market Cap
SHA:603882 has a market cap or net worth of 14.75 billion as of February 3, 2026. Its market cap has increased by 21.00% in one year.
Market Cap
14.75B
Enterprise Value
13.22B
Revenue
6.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
32.27
Market Cap Chart
Since September 8, 2017, SHA:603882's market cap has increased from 4.57B to 14.75B, an increase of 222.88%. That is a compound annual growth rate of 14.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 14.75B | 12.31% |
| Dec 31, 2025 | 13.14B | 3.91% |
| Dec 31, 2024 | 12.64B | -56.89% |
| Dec 29, 2023 | 29.33B | -19.71% |
| Dec 30, 2022 | 36.53B | -29.55% |
| Dec 31, 2021 | 51.85B | -11.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Joinn Laboratories(China)Co.,Ltd. | 25.79B |
| BGI Genomics | 19.31B |
| Dian Diagnostics Group | 15.11B |
| Shanghai Runda Medical Technology | 10.06B |
| Amoy Diagnostics | 8.27B |
| Beijing Strong Biotechnologies,Inc. | 7.70B |
| Cowealth Medical China | 7.31B |
| Maccura Biotechnology Co.Ltd | 7.29B |